Susan Shiff

Susan Patricia Shiff currently works at Huma.ai, Inc., as President, Chief Executive Officer & Director from 2024, Merck Global Health Innovation Fund LLC, as Director, Synthace Ltd., as Director from 2018, Tvardi Therapeutics, Inc., as Independent Director from 2025, and New Jersey Symphony Orchestra, as Trustee.
Dr. Shiff also formerly worked at CARA Therapeutics, Inc., as Independent Director, Merck & Co., Inc., as Senior Vice President from 2014 to 2021, Pfizer Inc., as Vice President, Teva Pharmaceutics, as Vice President-Global Health Economics, and Ontada LLC, as President from 2021 to 2023.
Dr. Shiff received her doctorate degree from the University of California, Los Angeles and Masters Business Admin degree from Cornell University.